Genetic and Pharmacological Regulation of the Endocannabinoid CB1 Receptor in Duchenne Muscular Dystrophy

Nature Communications - United Kingdom
doi 10.1038/s41467-018-06267-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

Therapy of Genetic Disorders: Novel Therapies for Duchenne Muscular Dystrophy

Current Pediatrics Reports
2014English

Disability and Survival in Duchenne Muscular Dystrophy

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2009English

Duchenne Muscular Dystrophy and Brain Function

2012English

Bladder Dysfunction in Duchenne Muscular Dystrophy

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2003English

The Population Genetics of Duchenne Muscular Dystrophy.

Journal of Medical Genetics
Genetics
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy